Hungarian pharma authority suggests suspending promotional activities in hospitals


Due to the deteriorating epidemiological situation in Hungary, the National Chief Medical Officer has ordered a ban on visits to all facilities providing inpatient specialised care in Hungary, effective from 1 November 2021.

In connection with this, the Hungarian pharmaceutical authority (OGYÉI) issued a communication applying the ban also to sales representatives engaged in promotional activities at healthcare providers providing inpatient care. The OGYÉI also recommends that all promotional activities requiring a physical presence which are aimed at healthcare professionals engaged in outpatient and basic care should be suspended too.

For further information on the Hungarian pharmaceutical industry, contact your regular CMS advisor or local CMS experts.